• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Progression to cirrhosis in Latinos with chronic hepatitis C: differences in Puerto Ricans with and without human immunodeficiency virus coinfection and along gender.

作者信息

Rodríguez-Torres Maribel, Ríos-Bedoya Carlos F, Rodríguez-Orengo José, Fernández-Carbia Alberto, Marxuach-Cuétara Acisclo M, López-Torres Abimael, Salgado-Mercado Rosa, Bräu Norbert

机构信息

Fundación de Investigación de Diego, San Juan, Puerto Rico.

出版信息

J Clin Gastroenterol. 2006 Apr;40(4):358-66. doi: 10.1097/01.mcg.0000210105.66994.dc.

DOI:10.1097/01.mcg.0000210105.66994.dc
PMID:16633110
Abstract

BACKGROUND

Hepatitis C virus (HCV) infection is prevalent in Latinos. There is some evidence that progression to cirrhosis is more rapid.

END POINTS

To calculate time of cirrhosis from time of HCV infection in a large Latino population. Other end points were to assess variables that predict cirrhosis and the effect of gender, alcohol, and human immunodeficiency virus (HIV) infection status on time to cirrhosis.

METHODS

Four hundred sixty-nine Latino patients evaluated at a referral center in Puerto Rico were included. Several demographic parameters, such as risk factors, estimated duration of HCV infection, alcohol use, HIV status, and findings from the usual HCV and HIV laboratory tests were noted. All patients had liver biopsy specimens assessed by Ishak score.

RESULTS

Monoinfected and coinfected latinos have a median cumulative risk/hazard for cirrhosis of 42.0 vs. 32.0 years after infection (P = 0.0016). The median age of cirrhotic patients is 53.0 years in monoinfections and 42.0 years in coinfection. Among coinfected patients there is no gender-associated difference in time to onset of cirrhosis (P = 0.785). Among monoinfected patients, males have a shorter median risk/hazard to cirrhosis than females (11.0-year difference; P = 0.05) and have a shorter time until onset of cirrhosis by fibrosis progression rate (FPR) (33.33 vs. 41.66 years; P = 0.021). There is no difference between male patients with regard to HIV status (P = 0.199). Alcohol use is significant in monoinfected males (59.2 g/day) vs. females (11.4 g/day; P = 0.001). Variables that predict cirrhosis are male sex, age, and Ishak grade in monoinfected patients and alanine aminotransferase value in coinfected patients.

CONCLUSIONS

Puerto Ricans with HCV have a median risk/hazard time to cirrhosis at younger age than other populations. Males who are HIV/HCV-coinfected have the same median risk/hazard and time to cirrhosis than those monoinfected with HCV. Special attention for early diagnosis and treatment is mandatory.

摘要

相似文献

1
Progression to cirrhosis in Latinos with chronic hepatitis C: differences in Puerto Ricans with and without human immunodeficiency virus coinfection and along gender.
J Clin Gastroenterol. 2006 Apr;40(4):358-66. doi: 10.1097/01.mcg.0000210105.66994.dc.
2
[Risk factors for the progression of chronic hepatitis C virus infection].[慢性丙型肝炎病毒感染进展的危险因素]
Rev Gastroenterol Peru. 2003 Apr-Jun;23(2):126-33.
3
Relating the liver damage with hepatitis C virus polymorphism in core region and human variables in HIV-1-coinfected patients.探讨丙型肝炎病毒核心区多态性与人类免疫缺陷病毒 1 型合并感染患者肝损伤的关系。
Infect Genet Evol. 2010 Dec;10(8):1252-61. doi: 10.1016/j.meegid.2010.08.009. Epub 2010 Aug 21.
4
Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.丙型肝炎病毒与人类免疫缺陷病毒合并感染患者中慢性丙型肝炎向肝纤维化和肝硬化的进展。
Clin Infect Dis. 2003 Feb 15;36(4):491-8. doi: 10.1086/367643. Epub 2003 Jan 31.
5
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.合并或未合并肝硬化的HIV与丙型肝炎病毒合并感染患者发生特定艾滋病界定疾病的风险。
Clin Infect Dis. 2009 Aug 15;49(4):612-22. doi: 10.1086/603557.
6
Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus.丙型肝炎病毒和人类免疫缺陷病毒合并感染患者的肝纤维化进展与CD4细胞耗竭有关。
J Infect Dis. 2001 Jan 1;183(1):134-7. doi: 10.1086/317644. Epub 2000 Nov 16.
7
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.人类免疫缺陷病毒合并感染对注射吸毒者慢性丙型肝炎的影响:一项长期回顾性队列研究。
Hepatology. 2001 Dec;34(6):1193-9. doi: 10.1053/jhep.2001.29201.
8
Estimating progression to cirrhosis in chronic hepatitis C virus infection.评估慢性丙型肝炎病毒感染患者进展为肝硬化的情况。
Hepatology. 2001 Oct;34(4 Pt 1):809-16. doi: 10.1053/jhep.2001.27831.
9
Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.印度慢性丙型肝炎病毒感染中肝纤维化进展的自然史
J Gastroenterol Hepatol. 2009 Apr;24(4):581-7. doi: 10.1111/j.1440-1746.2008.05649.x. Epub 2008 Nov 20.
10
[Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].[西班牙一所监狱囚犯中的慢性丙型肝炎病毒感染及相关肝病]
Enferm Infecc Microbiol Clin. 2009 Apr;27(4):206-12. doi: 10.1016/j.eimc.2008.07.003. Epub 2009 Feb 25.

引用本文的文献

1
No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients.在 HCV 单感染和 HCV/HIV 共感染患者中,DAA 治疗后非侵入性肝纤维化标志物 24 个月的进程中无性别差异。
Sci Rep. 2024 Mar 29;14(1):7534. doi: 10.1038/s41598-024-57845-x.
2
Sex-biased adaptive immune regulation in cancer development and therapy.癌症发生发展与治疗中的性别偏向性适应性免疫调节
iScience. 2022 Jul 4;25(8):104717. doi: 10.1016/j.isci.2022.104717. eCollection 2022 Aug 19.
3
Features of hepatocellular carcinoma in Hispanics differ from African Americans and non-Hispanic Whites.
西班牙裔肝细胞癌的特征与非裔美国人和非西班牙裔白人不同。
World J Hepatol. 2017 Mar 8;9(7):391-400. doi: 10.4254/wjh.v9.i7.391.
4
Chronic Hepatitis C: Treatment, Complications, and Long-term Outcomes in a Population of Latino Veterans.慢性丙型肝炎:拉丁裔退伍军人人群中的治疗、并发症及长期预后
P R Health Sci J. 2016 Mar;35(1):30-4.
5
Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis.注射吸毒者中的丙型肝炎病毒(HCV)疾病进展:一项系统评价和荟萃分析。
Int J Drug Policy. 2015 Oct;26(10):911-21. doi: 10.1016/j.drugpo.2015.07.004. Epub 2015 Jul 26.
6
SNPs in the promoter region of the osteopontin gene as a possible host factor for sex difference in hepatocellular carcinoma development in patients with HCV.骨桥蛋白基因启动子区域的单核苷酸多态性作为丙型肝炎病毒患者肝细胞癌发生性别差异的一种可能宿主因素。
Hepatol Int. 2013 Jun;7(2):683-92. doi: 10.1007/s12072-012-9404-1. Epub 2012 Oct 6.
7
Sex differences in immune responses to infectious diseases.免疫应答在感染性疾病中的性别差异。
Infection. 2015 Aug;43(4):399-403. doi: 10.1007/s15010-015-0791-9. Epub 2015 May 9.
8
Factors influencing liver fibrosis and necroinflammation in HIV/HCV coinfection and HCV monoinfection.影响 HIV/HCV 合并感染和 HCV 单感染患者肝纤维化和坏死性炎症的因素。
Infection. 2013 Oct;41(5):959-67. doi: 10.1007/s15010-013-0502-3. Epub 2013 Jul 10.
9
Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases.性别会影响对病毒的免疫反应,以及预防和治疗病毒疾病的效果。
Bioessays. 2012 Dec;34(12):1050-9. doi: 10.1002/bies.201200099. Epub 2012 Sep 26.
10
Predicting the probable outcome of treatment in HCV patients.预测 HCV 患者治疗的可能结果。
Therap Adv Gastroenterol. 2009 Sep;2(5):287-302. doi: 10.1177/1756283X09339079.